DOCSLIB.ORG

Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans: Combined Estrogen−Progestogen Contraceptives and Combined Estrogen− Progestogen Menopausal Therapy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans: Combined Estrogen−Progestogen Contraceptives and Combined Estrogen− Progestogen Menopausal Therapy IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS: COMBINED ESTROGEN−PROGESTOGEN CONTRACEPTIVES AND COMBINED ESTROGEN− PROGESTOGEN MENOPAUSAL THERAPY Lyon, 7–14 June 2005 LIST OF PARTICIPANTS Working Group Members1 Garnet L. Anderson, Women’s Health Initiative, Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-A410, PO Box 19024, Seattle, WA 98109, USA Philippe Autier, Unit of Epidemiology, Prevention and Screening, Jules Bordet Institute, Boulevard de Waterloo 125, Brussels 1000, Belgium Valerie Beral, Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Headington, Oxford OX3 7LF, United Kingdom (Subgroup Chair, Cancer in Humans) Maarten C. Bosland, Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA (Subgroup Chair, Other Relevant Data) Esteve Fernández, Cancer Prevention & Control Unit, Catalan Institute of Oncology, Avenue Gran Via s/n Km. 2.7, 08907 L’Hospitalet (Barcelona), Spain Sandra Z. Haslam ,Breast Cancer & the Environment Research Center, Department of Physiology, Michigan State University, 2201 Biomedical and Physical Sciences Building, East Lansing, MI 48824, USA David G. Kaufman2, Department Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, 620 Brinkhous-Bullitt Building, CB 7525, Chapel Hill, NC 27599-7525, USA 1 Working Group Members and Invited Specialists serve in their individual capacities as scientists and not as representatives of their government or any organization with which they are affiliated. Affiliations are provided for identification purposes only. 2 Received past research support from Organon (a unit of Akzo-Nobel). There are no discussions or expectations of future research support. –3– 4 IARC MONOGRAPHS VOLUME 91 Carlo La Vecchia, Laboratory of General Epidemiology, Mario Negri Institute, via Eritrea 62, 20157 Milan, Italy (Overall Chair) Alfredo A. Molinolo ,Oral & Pharyngeal Cancer Branch, National Institute of Dental & Craniofacial Research, Building 30, Room 213, 30 Convent Drive, Bethesda, MD 20892-4340, USA (Subgroup Chair, Cancer in Experimental Animals) Polly A. Newcomb (not present for evaluations), Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle WA98109, USA (Subgroup Chair, Exposure Data) Fritz F. Parl, Department of Pathology, The Vanderbilt Clinic TVC 4918, Vanderbilt Uni- versity Medical Center, 23rd Avenue South at Pierce Street, Nashville, TN 37232- 5310, USA Julian Peto, Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom Giuseppe Rosano3 (not present for evaluations), Cardiovascular Research Unit, Department of Medical Sciences, San Raffaele-Tosinvest Sanita, Via Suvereto 10, 00139 Roma (RM) – Lazio, Italy Deodutta Roy, Department of Environmental & Occupational Health, Robert Stempel School of Public Health, Florida International University, Building HLS 2, Room 591, 11200 SW 8th Street, Miami, FL 33199, USA Frank Z. Stanczyk (unable to attend), Reproductive Endocrine Research Laboratory, Women’s & Children’s Hospital, Keck School of Medicine, University of Southern California, 1240 N. Mission Road, Room 1M2, Los Angeles, CA 90033, USA David B. Thomas, Program in Epidemiology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109-1024, USA Lars Vatten, Department of Community Medicine & General Practice, Norwegian Univer- sity of Science & Technology, Eirik Jarls Gate 10, 6th floor, 7489 Trondheim, Norway Invited Specialists Ted Junghans, Technical Resources International Inc, 6500 Rock Spring Drive, Suite 650, Bethesda, MD 20817-1197, USA Steve Olin, ILSI Risk Science Institute, One Thomas Circle, NW, 9th Floor, Washington, DC 20005-5802, USA Samuel Shapiro4 ,Department of Public Health, University of Cape Town Medical School, Anzio Road, Observatory, South Africa Randall S. Stafford5, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1020, New Zealand 3 Receives a minor amount of travel support for talks sponsored by Solvay S.A. and Pfizer Inc. 4 Serves as a scientific consultant to Schering AG. Also received a minor amount of travel support to talk at a meeting sponsored by Organon (a unit of Akzo Nobel). 5 Received research support from Glaxo Smith Kline and is in discussions with them about future research support. PARTICIPANTS 5 Representative Charles William Jameson, Report on Carcinogens, National Institute of Environmental Health Sciences, PO Box 12233, 79, Alexander Drive, Research Triangle Park, NC 27709, USA Observer Observer for the European Federation of Pharmaceutical Industries and Associations (EFPIA) Jens U. Meyer6, Global Medical Development, Gynecology & Andrology, Central Medical Affairs, Schering AG, Müllerstrasse 178, 13342 Berlin, Germany IARC Secretariat Robert Baan, IARC Monographs programme (Rapporteur, Subgroup on Other Relevant Data) Julien Berthiller, Gene–Environment Epidemiology Vincent James Cogliano, IARC Monographs programme (Head of Programme) Carolyn Dresler, Tobacco and Cancer Fatiha El Ghissassi, IARC Monographs programme (Co-Rapporteur, Subgroup on Other Relevant Data) Silvia Franceschi, Infections and Cancer Epidemiology Maria-Alice G. Gonçalves, Gene–Environment Epidemiology Yann Grosse, IARC Monographs programme (Responsible Officer; Rapporteur, Subgroup on Cancer in Experimental Animals) Neela Guha, Gene–Environment Epidemiology Manuela Marron, Gene–Environment Epidemiology Jane Mitchell, IARC Monographs programme (Editor) Nikolai Napalkov, IARC Monographs programme Béatrice Secretan, IARC Monographs programme (Rapporteur, Subgroup on Exposure Data) Kurt Straif, IARC Monographs programme (Rapporteur, Subgroup on Cancer in Humans) Andreas Ullrich, Programme in Cancer Control, Department of Chronic Diseases and Health Promotion (CHP), World Health Organization, 20, Avenue Appia, 1211 Geneva 27, Switzerland Administrative assistance Sandrine Egraz Brigitte Kajo Martine Lézère Helene Lorenzen-Augros 6 Employed by Schering AG.
Load more

Recommended publications
  • Current Awareness Service, February, 2011
    Current Awareness Services February 2011 American Journal of Epidemiology Volume 172, Issue 7 (1October 2010) How to Be a Department Chair of Epidemiology: A Survival Guide Roberta B. Ness and Jonathan M. Samet Pages: 747-751 A Pooled Analysis of Extremely Low-Frequency Magnetic Fields and Childhood Brain Tumors L. Kheifets, A. Ahlbom, C. M. Crespi, M. Feychting, C. Johansen, J. Monroe, M. F. G. Murphy, S. Oksuzyan, S. Preston-Martin, E. Roman, T. Saito, D. Savitz, J. Schüz, J. Simpson, J. Swanson, T. Tynes, P. Verkasalo, and G. Mezei Pages: 752-761 ORIGINAL CONTRIBUTION A Melanoma Epidemic in Iceland: Possible Influence of Sunbed Use Clarisse Héry, Laufey Tryggvadóttir, Thorgeir Sigurdsson, Elínborg Ólafsdóttir, Bardur Sigurgeirsson, Jon G. Jonasson, Jon H. Olafsson, Mathieu Boniol, Graham B. Byrnes, Jean-François Doré, and Philippe Autier Pages: 762-767 Invited Commentary: Invited Commentary: A Sunbed Epidemic? Marianne Berwick Pages: 768-770 Response to Invited Commentary: Autier et al. Respond to “A Sunbed Epidemic?” Philippe Autier, Laufey Tryggvadóttir, Thorgeir Sigurdsson, Elínborg Ólafsdóttir, Bardur Sigurgeirsson, Jon G. Jonasson, Jon H. Olafsson, Graham B. Byrnes, Clarisse Héry, Jean- François Doré, and Mathieu Boniol Pages: 771-772 Alcoholic Beverages and Prostate Cancer in a Prospective US Cohort Study Joanne L. Watters, Yikyung Park, Albert Hollenbeck, Arthur Schatzkin, and Demetrius Albanes Pages: 773-780 The Potentially Modifiable Burden of Incident Heart Failure Due to Obesity: The Atherosclerosis Risk in Communities Study Laura R. Loehr, Wayne D. Rosamond, Charles Poole, Ann Marie McNeill, Patricia P. Chang, Anita Deswal, Aaron R. Folsom, and Gerardo Heiss Pages: 781-789 Chronic and Acute Effects of Coal Tar Pitch Exposure and Cardiopulmonary Mortality Among Aluminum Smelter Workers Melissa C.
    [Show full text]
  • Operational Guidance Forvictim Assistance Responsive to Gender
    Victim assistance responsive to gender and other diversity aspects OPERATIONAL GUIDANCE The present publication was produced thanks to the financial support of the Italian Cooperation. Its content, however, is the sole responsibility of GMAP and does not reflect the views of the Italian Government. Table of contents List of abbreviations 5 Acknowledgments 6 Foreword 8 Introduction 11 Purpose of the operational guidance 14 Audience 15 Methodology 16 Limitations 17 Definitions 17 Structure 21 Services 23 Understanding the challenges (data collection) 23 Emergency and ongoing medical care 30 Rehabilitation 31 Psychological and psycho-social support 34 Socio-economic inclusion 37 Laws and policies 43 Affected States 45 Donors 49 Sources 51 Guidelines and Reports 51 Academic articles 55 Blogs, study cases and witnesses 57 © Jorge Henao, Colombia, 2010. GMAP - Guidances 2018 - Abbreviations & Preface Abbreviations ACAP III: Afghan Civilian Assistance Program ALSO: Afghanistan Landmine Survivor Organisation APMBC: Anti-Personnel Mine Ban Convention CCD: Community Center for the Disabled CCM: Convention on Cluster Munitions CCW: Convention on Certain Conventional Weapons CEDAW: Convention on the Elimination of all forms of Discrimination Against Women CRC: Convention on the Rights of the Child CRPD: Convention on the Rights of Persons with Disabilities DCP: Disability Creation Process ERW: Explosive Remnants of War GMAP: Gender and Mine Action Programme HI: Humanity & Inclusion (formerly known as Handicap International) HQ: Headquarters ICF:
    [Show full text]
  • Menstrual and Reproductive Factors, Hormone Use and Risk of Pancreatic Cancer: Analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Pancreas Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 November 01. Published in final edited form as: Pancreas. 2016 November ; 45(10): 1401–1410. doi:10.1097/MPA.0000000000000635. Menstrual and Reproductive Factors, Hormone Use and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (Panc4) Leila Lujan-Barroso, MsC, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain Wei Zhang, PhD, Department of Epidemiology, Shanghai Cancer Institute and Jiao Tong University, Shanghai, China Sara H. Olson, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY Yu-Tang Gao, PhD, Department of Epidemiology, Shanghai Cancer Institute and Jiao Tong University, Shanghai, China Herbert Yu, PhD, Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA Peter A. Baghurst, PhD, Public health, Women’s and Children’s Hospital, Adelaide, SA, Australia Paige M. Bracci, PhD, University of California, San Francisco, San Francisco, CA, USA H. Bas Bueno-de-Mesquita, MD, PhD, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Lenka Foretová, PhD, Corresponding author: Eric J Duell, MS, PhD, Senior Investigator/Epidemiologist, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Avda Gran Via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain, tel: +34 93 260 7401 (ext 3354), fax: +34 93 260 7787, [email protected].
    [Show full text]
  • Meal Frequency and Risk of Colorectal Cancer1
    [CANCER RESEARCH 52. 3589-3592. July 1, 1992] Meal Frequency and Risk of Colorectal Cancer1 Silvia Franceschi,2 Carlo La Vecchia, Ettore Bidoli, Eva Negri, and Renato Talamini Epidemiology Unit, Aviario Cancer Center, Via Pedemontana Occidentale, 33081 Avlano (PN), [S. F., E. B., R. T.]; Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan fC. L. K, E. N.J, Italy; and Institute of Social and Preventive Medicine, University of Lausanne, Bugnon 17, 1005 Lausanne, Switzerland 1C. L. V.J ABSTRACT PATIENTS AND METHODS The relation between meal frequency and the risk of colorectal cancer The present data were derived from an ongoing case-control study was investigated in a case-control study conducted in North Italy on 889 of several neoplasms of the digestive tract based on a network of cases of colon cancer, 581 cases of rectal cancer, and 2475 controls teaching and general hospitals from Greater Milan area and Pordenone province, North Italy (8-12). Recruitment of cases of colorectal cancer admitted to hospital for acute, nonneoplastic, or digestive disorders. As compared to individuals who reported 2 or fewer meals per day, the started in January 1985. All the interviews were conducted in hospital mull¡variatecolon cancer odds ratios were 1.7 [95% confidence interval before December 1990 and approximately 2% of cases and 3% of (95% CI), 1.5-2.11 for 3, and 1.9 (95% CI, 1.1-3.3) for 4 meals or more. control subjects refused to be interviewed. Corresponding rectal cancer odds ratios were 1.4 (95% CI, 1.1-1.7) for The cases studied were subjects with histologically confirmed large 3, and 1.9 (95% CI, 1.1-3.5) for 4 meals or more.
    [Show full text]
  • Ipri Biennial Report 2015 - 2016
    12/2016 Creation iPRI Africa 07/2016 12th NCID 07/2015 11th NCID 06/2011 07/2011 7th NCID Epidemiology and Biostatistics 02/2012 World Published Breast Cancer Report Published 12/2009 MOU 07/2014 10th NCID U. Dundee 07/2010 First Summer School 10/2013 State of Oncology 2013 07/2010 6th NCID Published iPRI 04/2009 iPRI Founded 06/2012 Boyle 07/2013 9th NCID awarded LLD (honoris causa) 12/2010 Boyle Inducted Hungarian Science Academy 09/2012 Autier PhD Erasmus University 07/2010 06/2013 Creation of World Prevention Alliance Strathclyde Institute of 01/2013 Founded Global Public Health at iPRI Mullie professorship VUB 03/2013 Alcohol: Science, Policy and Public Health Published iPRI Biennial Per indicium ad excellentia R e port 2015 - 2016 © iPRI 2017 Biennial Report International Prevention Research Institute 95 Cours Lafayette 69006 Lyon, France +33472171199 | www.i-pri.org | [email protected] 2015 - 2016 Are we moving too fast? Perhaps we are - going too fast. Perhaps we are driving ahead, leaving too many people behind, quite literally in the dust. Perhaps we are not doing enough for the disen- franchised in low resource countries and for the poorest among us. iPRI believes in progress. We believe in providing the best possible evidence for better global health. But we are doubly committed to ensuring that our knowledge be a conduit for better health, not just in privileged quarters, but in the most destitute ones as well. All scientific and policy roads must lead to prevention and better health for all. iPRI Biennial Report 2015 - 2016 ©2017, International Prevention Research Institute, Lyon, France Contents cannot be copied or otherwise reproduced without express consent of iPRI.
    [Show full text]
  • The Journal of Disaster Studies and Management
    Volume 13 No. 1 1989 The Journal of Disaster Studies and Management Contents Agriculture and Food Security in Ethiopia NICHOLAS WINER The Food and Nutrition Surveillance Systems of Chad and Mali: the "SAP" after two years P. AUTIER et al. The Relief Operation in Puno District, Peru, after the 1986 Floods of Lake Titicaca L. SZTORCH, V. GICQUEL and J.C. DESENCLOS The Role of Socio-Economic Data in Food Needs Assessment and Monitoring J. SHOHAM and E. CLAY Diet and Nutrition during Drought: an Indian Experience N. PRALHAD RAO A case Study of Social Behaviour in a Natural Disaster: the Olivares landslide (Spain) J.L.G. GARCIA and M.V.S. PARRA Experiences of Non-Governmental Organisations in the Targeting of Emergency Food Aid J. BORTON and J. SHOHAM Seminar on Bangladesh Floods H. BRAMMER International Conference on the greenhouse effect and coastal areas of Bangladesh H. BRAMMER Forthcoming Events Book Reviews Basil Blackwell for the Relief and Development Institute DISASTERS The Journal of Disaster Studies and Management EDITOR Fred Cuny, Intertect, Derrick Jelliffe, School of Charles Melville, Faculty of Dallas, Texas Public Health, University of Oriental Studies, Bruce Currey Winrock California, Los Angeles University of Cambridge international Institute for ^ ^echat. Centre de ASSISTANT EDITOR Agricultural Development, Recherche sur Susan York, Relief and Bangladesh 1'Epidemiologie des Development Institute lan Davis, Disaster Desastres, 1'Ecole de Sante EDITORIAL BOARD ^"^ puu ue Universite oxford^TT ^ oxfordo , ^ ' Hugh Brammer, Relief P^Y ^^ ' ^ Catholique de Louvain, and Development Institute Frances D'Souza, Dept. of Brussels (Book Reviews Editor) Biological Anthropology, _, , , University of Oxford /-i.
    [Show full text]
  • Resource Mobilization: Methodological Guidelines
    Resource Mobilization: Methodological Guidelines Mukesh Chawla Research Associate Data for Decision Making Project Department of Population and International Health Harvard School of Public Health Peter Berman Associate Professor of International Health Economics Department of Population and International Health Harvard School of Public Health August 1996 Data for Decision Making Project Table of Contents Acknowledgements ....................................................................................... 1 1. Introduction ........................................................................................... 2 2. Strategies for Resource Mobilization ........................................................ 5 3. Tax Revenues ......................................................................................... 8 4. User Charges ........................................................................................ 11 Design and Implementation of User Fees ....................................................... 12 Impact of User Fees on the Health System .................................................... 16 5. Health Insurance .................................................................................. 24 Design and Implementation of Insurance System ............................................ 27 Impact of Insurance on the Health System .................................................... 32 6. Guidelines for the DDM/HHRAA Field Case Studies ................................. 37 Objectives ...............................................................................................
    [Show full text]
  • Monday, 4Th November 2019 Cohort Updates Progress in ACC Research
    PROGRAM 2019 ANNUAL MEETING OF ACC – ILCEC: ONCOLOGY RESEACH & APPLICATION OF BIOBANK Vinmec International Clinic, Hanoi 4th – 6th November 2019 Time Topic Presenter Monday, 4th November 2019 8:00 – 10:00 ACC Executive Committee (closed meeting) ACC Executive Committee members 9:30-10:00 Registration Opening Prof. Paolo Boffetta 10:00 – 10:30 Welcome; Opening remarks Icahn School of Medicine at Mount Sinai, USA Manami Inoue, Eiko Saito, Sarah K. Abe, 10:30 – 11:00 Update of the ACC Coordinating Center Rashedul Islam National Cancer Center, Japan Cohort Updates Dr. Arash Etemadi 11:00 – 11:15 Persian Cohort National Cancer Institute, NIH Dr. Yi-Ling Lin 11:15 – 11:30 Taiwan Biobank update Institute of Biomedical Sciences, Academia Sinica, Taiwan Dr. Xifeng Wu 11:30 – 11:45 Taiwan cohort Prof. Rui Lin 11:45 – 12:00 Guangxi Cohort Guangxi Medical University, China 12:00 – 13:30 Lunch (Visit to Vinmec Hospital) Prof. Keun-Young Yoo 13:30-14:00 Plenary lecture Seoul National University College of Medicine, Korea Progress in ACC research (15 min each) Acute effect of ambient air pollution on health in PhD. Nguyen Thi Trang Nhung 14:00 – 14:15 Northern Vietnam Hanoi University of Public Health, Vietnam PM concentration mapping from satellite images PhD. Nguyen Thi Nhat Thanh 14:15 – 14:30 for health impact assessment in Vietnam Vietnam National University Dr. George Downward Long-term ambient air pollution and mortality in 14:30 – 14:45 Institute for Risk Assessment Sciences, Utrecht the ACC, project update University, Netherlands Household Air Pollution Consortium (HAPCO) A/Prof. Dean Hosgood 14:45 – 15:00 updates Albert Einstein College of Medicine, USA 15:00 – 15:30 Coffee break (Poster session) Lifetime Overweight and Obesity: Impact on Dr.
    [Show full text]
  • Medical History and Primary Liver Cancer1
    [CANCER RESEARCH 50, 6274-6277. October I. 1990] Medical History and Primary Liver Cancer1 Carlo La Vecchia, Eva Negri, Barbara D'Avanzo, Peter Boyle, and Silvia Franceschi Istituto di Ricerche Farmaco/logiche "Mario Negri," 20157 Milan, Italy [C. L. V., E. N., B. D.]; Institute of Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland ¡C.L. V.¡;Unitof Analytical Epidemiology, The International Agency for Research on Cancer, Lyon, France ¡P.B.f;and Servizio di Epidemiologia, Centro di Riferimento Oncologico, 33081 Ariano (PN), Italy [S. F.] ABSTRACT The general structure of this investigation has already been described (12). Briefly, trained interviewers identified and questioned cases and The relationship between selected aspects of medical history and the controls in the major teaching and general hospitals of the Greater risk of primary liver cancer was analyzed in a hospital-based case-control Milan area. The structured questionnaire included information on study conducted in Northern Italy on 242 patients with histologically or sociodemographic characteristics, smoking habits, alcohol drinking, serologically confirmed hepatocellular carcinoma and 1169 controls in intake of coffee and 14 selected indicator foods, and a problem-oriented hospital for acute, nonneoplastic, or digestive diseases. Significant asso medical history including 12 selected diseases or interventions. By ciations were observed for clinical history of hepatitis (odds ratio (OR), definition, the diseases or interventions considered had to anticipate by 3.7; 95% confidence interval (CI), 2.3-5.9], cirrhosis (OR, 16.8; 95% CI, at least 1 year the onset of the symptoms of the disease which led to 9.8-28.8), and three or more episodes of transfusion in the past (OR, admission.
    [Show full text]
  • Section of Early Detection & Prevention (Edp)
    SECTION OF EARLY DETECTION & PREVENTION (EDP) THE SECTION OF EARLY DETECTION AND PREVENTION COMPRISES THREE GROUPS: Section Head THE PREVENTION GROUP (PRE), THE QUALITY ASSURANCE GROUP (QAS) AND THE Dr Rengaswamy Sankaranarayanan SCREENING GROUP (SCR). The Section seeks to provide evidence as to which primary and secondary prevention interventions are appropriate, effective and cost-effective in lowering the global burden of breast, cervical, oral, colorectal, skin and prostate cancers. This approach includes studying the means to implement integrated and quality-assured interventions in routine settings in different parts of the world. These research topics are in tune with the overall mission of the Agency in that they aim to reduce cancer burden by prevention. SECTION OF EARLY DETECTION & PREVENTION 105 106 biENNIAL REPORT 2008/2009 PREVENTION GROUP (PRE) Group Head Dr Philippe Autier Scientists Dr Mathieu Boniol Dr Graham Byrnes (until April 2009-moved to CIN/BST) Secretariat Ms Asiedua Asante Ms Anne Sophie Hameau (until March 2008) Ms Laurence Marnat (February 2008-May 2008) Visiting scientists Prof Brian Cox (from June 2008 to December 2008) Dr Jean-Francois Dore Dr Jan Alvar Lindencrona (until March 2008) Ms Carolyn Nickson (March 2009-May 2009) Prof Peter Selby (July 2009-December 2009) Ms Mary Jane Sneyd (June 2009-December 2009) Clerks Ms Murielle Colombet (until December 2008) Myriam Adjal (until February 2009) Students Lorraine Bernard (February 2008-August 2008) Maria Bota (July 2008-August 2008) Anne Elie Carsin (January 2008-April 2008) Gwendoline Chaize (May 2008-August 2008) Clementine Joubert (March 2008-August 2008) Alice Koechlin (May 2009-August 2009) Anthony Montella (June 2008-August2008) PhD students: Clarisse Hery (from June 2008) Isabelle Chaillol (from October 2008) PREVENTION GROUP 107 THE OVERALL GOAL OF THE PREVENTION GROUP IS TO EVALUATE THE IMPACT OF PREVENTION ACTIVITIES.
    [Show full text]
  • Mammography Screening Shows Limited Effect on Breast Cancer Mortality in Sweden
    Journal of the National Cancer Institute Contact: Zachary Rathner [email protected] 301-841-1286 CI Mammography Screening Shows Limited Effect on Breast Cancer Downloaded from https://academic.oup.com/jnci/article/104/14/NP/2517022 by guest on 01 October 2021 Mortality in Sweden Breast cancer mortality statistics in Sweden are consistent with studies that have reported that screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a study published July 17 in the Journal of the National Cancer Institute. Since 1974, Swedish women aged 40-69 have increasingly been offered mammography screening, with nationwide cover- age peaking in 1997. Researchers set out to determine if mortality trends would be reflected accordingly. In order to determine this, Philippe Autier, M.D., of the International Prevention Research Institute (iPRI) in France and colleagues, looked at data from the Swedish Board of Health and Welfare from 1960-2009 to analyze trends in breast cancer mortality in women aged age 40 and older by the county in which they lived. The researchers compared actual mortality trends with the theoretical outcomes using models in which screening would result in mortality reductions of 10%, 20%, and 30%. The researchers expected that screening would be associated with a gradual reduction in mortality, especially because Swedish mammography trials and observational studies have suggested that mammography leads to a reduction in breast cancer mortality. In this study, however, they found that breast cancer mortality rates in Swedish women started to decrease in 1972, before the introduction of mammography, and have continued to decline at a rate similar to that in the prescreening period.
    [Show full text]
  • Sommario Biografico Prof. Carlo La Vecchia Il Prof. Carlo La Vecchia È
    Sommario Biografico Prof. Carlo La Vecchia Il Prof. Carlo La Vecchia è Professore di Epidemiologia all’Università di Milano. È inoltre Adjunct Professor of Medicine, School of Medicine, Vanderbilt University, Nashville, TN (2002-2016). È temporary advisor all’Organizzazione Mondiale della Sanità a Ginevra, ed è iscritto all’Ordine dei Medici e dei Giornalisti di Milano. I principali argomenti di interesse includono l’epidemiologia dei tumori e i rischi associati a dieta tabacco contraccettivi orali ed esposizioni occupazionali od ambientali ad agenti tossici, analisi degli andamenti temporali e della distribuzione geografica nella mortalità per tumori, malattie cardiovascolari, patologie perinatali e altre malattie importanti. È autore o coautore di oltre 2200 pubblicazioni su questi argomenti (oltre 1840 incluse in Pubmed), che hanno ricevuto oltre 75.000 citazioni (H index 123) Il Prof. La Vecchia è stato Professore Associato Aggiunto di Epidemiologia alla Harvard School of Public Health (1996-2001) , Honorary and Senior Lecturer in Medicina Stomatologica alla Eastman Dental Institute, University College London (1996-2003) . È stato Professore Straordinario di Epidemiologia, Istituto di Medicina Sociale e Preventiva, Università di Losanna, Svizzera (dal 2002-14) e Consulente Senior alla International Agency for Research on Cancer , IARC/OMS (2007-9), Capo Dipartimento di Epidemiologia all’Istituto Mario Negri, Milano (2007-14). È editor di Epidemiology,Biostatistics and Pubhlic Health. E’Associate Editor di dell’European Journal of Cancer Prevention. E’ stato Editor dell’ European Journal of Public Health e del Journal of Epidemiology and Biostatistics e Associate Editor di Annals of Oncology . Nel 2002 è stato nominato “ISI Thompson Higly quoted scientist (Medicine) e nel 2006 Commendatore della Repubblica Italiana per meriti scientifici.
    [Show full text]